Sun Pharma: sixth time lucky

JPMorgan brings bought deal for Indian drugs company.

A $225 million convertible for Sun Pharma was completed after London's close on Wednesday. The deal represents the largest ever sole books offering from India and underlines JPMorgan's continuing aggression towards its equity-linked franchise.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media